Gynecologic Cancer News

The 2018 introduction of calorie labels to restaurant menus appears to have yielded a net reduction in caloric intake of 20 to 60 calories per meal among Americans, potentially reducing risk for obesity-associated cancers.

Mary B. Daly, MD, PhD, FACP, has been named the inaugural recipient of the BRCA Impact Award, presented by Penn Medicine’s Basser Center for BRCA.

Survivors of cancer in adolescence and young adulthood face increased risk for subsequent HPV-related cancer diagnoses, according to research conducted at University of Utah’s Huntsman Cancer Institute.

So far in 2023, there has been an overwhelming shortage of chemotherapy drugs, of which several specifically impact gynecologic oncology providers and patients.

Researchers at The Ohio State University have launched an international clinical trial that will compare minimally invasive robotic surgery with open surgery for women undergoing radical hysterectomy for cervical cancer.

FDA announced the creation of a voluntary pilot program that will assist clinicians in selecting the appropriate treatment for patients with cancer through the use of laboratory-developed tests, according to an FDA press release.

ASCO Chief Medical Officer Julie R. Gralow, MD, FACP, FASCO, urged members of Congress to take action on cancer drug shortages, which she described as the worst she has witnessed during her 30-year career in oncology.

CHICAGO — Healio | HemOnc Today gathered the best, brightest and boldest in oncology for its second annual Disruptive Innovators Awards.

CHICAGO — Mirvetuximab soravtansine-gynx extended survival of women with platinum-resistant ovarian cancer and high folate receptor-alpha expression, according to a study that compared the agent with investigator’s choice of chemotherapy.

CHICAGO — Higher tumor mutational burden appeared associated with more favorable real-world OS among a large cohort of patients with various cancer types who used immune checkpoint inhibitor monotherapy.